GlaxoSmithKline Chairman Philip Hampton to Step Down
21 Enero 2019 - 1:39AM
Noticias Dow Jones
By Adria Calatayud
GlaxoSmithKline PLC (GSK.LN) said Monday that Chairman Philip
Hampton intends to step down after nearly four years in the
role.
The board of the FTSE 100 pharmaceutical company has started the
process to find a successor, it said.
"Following the announcement of our deal with Pfizer and the
intended separation of the new consumer business, I believe this is
the right moment to step down and allow a new Chair to oversee this
process through to its conclusion over the next few years and to
lead the Board into this next phase for GSK," Mr. Hampton said.
Mr. Hampton joined GlaxoSmithKline's board on Jan. 1 2015 and
became chairman on May 7, 2015.
Write to Adria Calatayud at
adria.calatayudvaello@dowjones.com
(END) Dow Jones Newswires
January 21, 2019 02:24 ET (07:24 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
